el-Dalil A, Radcliffe K W, Bailey J, Richmond R A, Wade A A
Department of Genitourinary Medicine, Coventry and Warwickshire Hospital, UK.
Genitourin Med. 1995 Aug;71(4):251-3. doi: 10.1136/sti.71.4.251.
To determine the policies applied in genitourinary medicine (GUM) departments in the United Kingdom (UK) and Ireland with regard to hepatitis B vaccination.
All genitourinary medicine consultants were sent a questionnaire requesting information concerning their selection criteria and the management of patients offered Hepatitis B vaccine. If no response was obtained a second questionnaire was sent. The survey was carried out in 1993.
All genitourinary medicine departments in UK and Ireland.
234 consultants were sent the questionnaire. 153 consultants responded.
Overall, there was a 65.4% response rate to the questionnaire. Almost all genitourinary physicians would offer the vaccine to male homosexuals and up to 74% offer it to all male homosexuals, intravenous drug users (IVDU) and prostitutes. Of the genitourinary physicians, 96% agreed that hepatitis B virus (HBV) serological markers should be checked prior to or simultaneously with vaccination, yet there was no agreement as to which marker should be performed. Up to 79% of consultants recalled the patients to check their response to vaccination but only 61% offered long term follow up after vaccination.
HBV vaccine is offered to all male homosexuals, IVDU and prostitutes in GUM departments. Currently, the vaccine is not generally offered to patients who present with sexually transmitted diseases. Almost all genitourinary physicians (96%) agree that HBV serological markers should be checked prior to or simultaneously with the start of the vaccination course and 80% would request hepatitis B surface antibody levels after vaccination to identify inadequate responders and non-responders. From this survey, there appears to be a need for uniform post-vaccination HBV screening and timing and frequency of booster doses.
确定英国和爱尔兰的泌尿生殖医学(GUM)科室在乙肝疫苗接种方面所采用的政策。
向所有泌尿生殖医学顾问发送问卷,询问有关他们的选择标准以及为提供乙肝疫苗的患者所进行的管理方面的信息。若未收到回复,则发送第二份问卷。该调查于1993年开展。
英国和爱尔兰的所有泌尿生殖医学科室。
向234名顾问发送了问卷。153名顾问做出了回应。
总体而言,问卷回复率为65.4%。几乎所有泌尿生殖科医生都会为男同性恋者提供疫苗,高达74%的医生会为所有男同性恋者、静脉吸毒者(IVDU)和妓女提供疫苗。在泌尿生殖科医生中,96%的人同意在接种疫苗前或同时应检查乙肝病毒(HBV)血清学标志物,但对于应检测哪种标志物并未达成一致。高达79%的顾问会召回患者以检查其对疫苗接种的反应,但只有61%的人在接种疫苗后提供长期随访。
泌尿生殖医学科室会为所有男同性恋者、静脉吸毒者和妓女提供乙肝疫苗。目前,通常不会为患有性传播疾病的患者提供该疫苗。几乎所有泌尿生殖科医生(96%)都同意在开始接种疫苗疗程前或同时应检查HBV血清学标志物,80%的医生会在接种疫苗后检测乙肝表面抗体水平,以识别接种反应不足者和无反应者。从本次调查来看,似乎需要统一接种疫苗后的乙肝筛查以及加强剂量的时间和频率。